Systems Perturbation Analysis of a Large Scale Signal Transduction Model Reveals Potentially Influential Candidates for Cancer Therapeutics

TL;DR

This study uses systemic perturbation analysis of a large-scale signal transduction model to identify influential components and potential cancer drug targets, highlighting combinatorial strategies like PI3K inactivation and IP3R1 overactivation for therapeutic benefit.

Contribution

The paper introduces a comprehensive perturbation analysis of a large-scale signal transduction model to identify influential and druggable components, including novel combinations for cancer therapy.

Findings

Identified key influential components affecting system dynamics.

Predicted novel drug target combinations, such as PI3K inactivation with IP3R1 overactivation.

Suggested systematic perturbation analysis as a method for discovering therapeutic targets.

Abstract

Dysregulation in signal transduction pathways can lead to a variety of complex disorders, including cancer. Computational approaches such as network analysis are important tools to understand system dynamics as well as to identify critical components that could be further explored as therapeutic targets. Here, we performed perturbation analysis of a large-scale signal transduction model in extracellular environments that stimulate cell death, growth, motility, and quiescence. Each of the model's components was perturbed under both loss-of-function and gain-of-function mutations. We identified the most and least influential components based on the magnitude of their influence on the rest of the system. Based on the premise that the most influential components might serve as better drug targets, we characterized them for biological functions, housekeeping genes, essential genes, and druggable proteins. Moreover, known cancer drug targets were also classified in influential components based on the affected components in the network. Additionally, the systemic perturbation analysis of the model revealed a network motif of most influential components which affect each other. Furthermore, our analysis predicted novel combinations of cancer drug targets with various effects on other most influential components. We found that the combinatorial perturbation consisting of PI3K inactivation and overactivation of IP3R1 can lead to increased activity levels of apoptosis-related components and tumor suppressor genes, suggesting that this combinatorial perturbation may lead to a better target for decreasing cell proliferation and inducing apoptosis. Lastly, our results suggest that systematic perturbation analyses of large-scale computational models may serve as an approach to prioritize and assess signal transduction components in order to identify novel drug targets in complex disorders.